Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

Autor:	Oliver Flossmann, Neeraj Dhaun, Charles D. Pusey, Stephen P. McAdoo, Rona M Smith, David D'Cruz, Fiona A Pearce, Lucy Smyth, Paul A. Brogan, Richard A. Watts, Peter Lanyon, Lisa C. Willcocks, Chetan Mukhtyar, Lorraine Harper, Alan D. Salama, David Jayne, Joanna Robson, Raashid Luqmani, Rachel B Jones, Joanna Tieu, Neil Basu
Rok vydání:	2020
Předmět:	medicine.medical_specialty Neutropenia Delphi Technique MEDLINE Microscopic Polyangiitis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis ANCA-Associated Vasculitis Churg-Strauss Syndrome Pneumococcal Infections Maintenance Chemotherapy Pneumococcal Vaccines Hypogammaglobulinemia Immunocompromised Host Rheumatology Agammaglobulinemia Recurrence Internal medicine Influenza Human Trimethoprim Sulfamethoxazole Drug Combination medicine Humans Pneumocystis jirovecii Pharmacology (medical) Duration of Therapy biology business.industry Pneumonia Pneumocystis Granulomatosis with Polyangiitis Expert consensus medicine.disease biology.organism_classification Trimethoprim United Kingdom Pneumonia Influenza Vaccines Antirheumatic Agents Practice Guidelines as Topic Rituximab business medicine.drug
Zdroj:	Rheumatology. 59:e24-e32
ISSN:	1462-0332 1462-0324
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c384a89d6a9c3bba2d3b3eb6dbc93d7b https://doi.org/10.1093/rheumatology/kez640 Zobrazit plný text záznamu